Changes in Serum and Urine N-Telopeptide Levels of Postmenopausal Osteoporotic Patients Within 6-months of Risedronate Treatment - Original Investigation

Changes in Serum and Urine N-Telopeptide Levels of Postmenopausal Osteoporotic Patients Within 6-months of Risedronate Treatment - Original Investigation

Aim: N-Telopeptides (NTX), which are known as bone turnover markers are being increasingly used in early diagnosis of osteoporosis, determining the fracture risk and following up of the treatment outcome. Material and Method: In this study serum and urine NTX levels of postmenapousal patients [ages...

Full description

Bibliographic Details
Main Authors: Murat Zinnuroğlu, Aylin Sepici Dinçel, Vesile Sepici, Gülçin Kaymak Karataş
Format: Article
Language:English
Published: Galenos Yayinevi 2006-09-01
Series:Türk Osteoporoz Dergisi
Subjects:
Bone markers
Serum N-telopeptide
ürine N-telopeptide
risedronate
postmenopausal osteoporosis
Online Access:http://www.turkosteoporozdergisi.org/article_4154/Changes-In-Serum-And-Urine-N-telopeptide-Levels-Of-Postmenopausal-Osteoporoticpatients-Within-6-months-Of-Risedronate-Treatment-Original-Investigation

Internet

http://www.turkosteoporozdergisi.org/article_4154/Changes-In-Serum-And-Urine-N-telopeptide-Levels-Of-Postmenopausal-Osteoporoticpatients-Within-6-months-Of-Risedronate-Treatment-Original-Investigation

Similar Items